Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
Freddie C HamdyJenny L DonovanJ Athene LaneChris MetcalfeMichael DavisEmma L TurnerRichard M MartinGrace J YoungEleanor I WalshRichard J BryantPrasad BollinaAndrew DobleAlan DohertyDavid GillattVincent GnanapragasamOwen HughesRoger KockelberghHoward KynastonAlan PaulEdgar PaezPhilip PowellDerek J RosarioEdward RoweMalcolm MasonJames W F CattoTim J PetersJon OxleyNaomi J WilliamsJohn StaffurthDavid E Nealnull nullPublished in: The New England journal of medicine (2023)
After 15 years of follow-up, prostate cancer-specific mortality was low regardless of the treatment assigned. Thus, the choice of therapy involves weighing trade-offs between benefits and harms associated with treatments for localized prostate cancer. (Funded by the National Institute for Health and Care Research; ProtecT Current Controlled Trials number, ISRCTN20141297; ClinicalTrials.gov number, NCT02044172.).
Keyphrases
- prostate cancer
- radical prostatectomy
- healthcare
- quality improvement
- minimally invasive
- early stage
- public health
- palliative care
- mental health
- radiation therapy
- radiation induced
- combination therapy
- percutaneous coronary intervention
- atrial fibrillation
- chronic pain
- social media
- human health
- decision making
- acute coronary syndrome